Altimmune Inc (ALT)

Sector:

HEALTH CARE

Industry:

BIOTECHNOLOGY & LIFE SCIENCES

SIC:

PHARMACEUTICAL PREPARATIONS

CEO:

Vipin K. Garg

Employees:

50

19 FIRSTFIELD ROAD, GAITHERSBURG, MD 20878

2406541450

Altimmune, Inc. focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis.

Data derived from most recent annual or quarterly report
Market Cap	745.251 Million	Shares Outstanding	49.159 Million	Avg 30-day Volume	1.402 Million
P/E Ratio	0.0	Dividend Yield	0.0	EPS
Price to Revenue	189.6118	Debt to Equity	0.022	EBITDA	-88.307 Million
Price to Book Value	3.0698	Operating Margin	-2670.1276	Enterprise Value	432.034 Million
Current Ratio	13.404	EPS Growth	0	Quick Ratio	12.861
1 Yr BETA	1.1664	52-week High/Low	23.49 / 3.83	Profit Margin	-2619.2678
Operating Cash Flow Growth	3.3163	Altman Z-Score	16.1957	Free Cash Flow to Firm	-58.805 Million
Earnings Report	2023-03-15

Healthcare Acquisition Corp

Are you looking for this stock instead?

iShares Diversified Alternatives Trust Index Fund

View SEC Filings from ALT instead.

View recent insider trading info

Altimmune Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Funds Holding ALT (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Click for Additional Filters

Market Value:

to

Ranking:

to

% of portfolio

to

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

4: filed on 2023-02-02 by ROBERTS M SCOT

4: filed on 2023-02-02 by HARRIS MATTHEW SCOTT

4: filed on 2023-02-02 by GARG VIPIN K

4: filed on 2023-02-02 by EISENSTADT RICHARD I

4: filed on 2023-02-01 by GARG VIPIN K

4: filed on 2023-02-01 by ROBERTS M SCOT

4: filed on 2023-02-01 by EISENSTADT RICHARD I

4: filed on 2023-02-01 by HARRIS MATTHEW SCOTT

4: filed on 2023-01-03 by EISENSTADT RICHARD I

4: filed on 2022-12-22 by PISANO WAYNE

Events (8k)

8-K: filed on 2022-12-20:

Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-11-10:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-09-29:

Item 5.07: Submission of Matters to a Vote of Security Holders

8-K: filed on 2022-09-14:

Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-08-11:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-05-12:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-03-15:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2021-12-17:

Item 1.02: Termination of a Material Definitive Agreement

8-K: filed on 2021-12-13:

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2021-11-09:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Proxy

Prospectus

424B5: filed on 2021-02-25

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

20 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

61.4 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
EISENSTADT RICHARD I CHIEF FINANCIAL OFFICER	Officer	12,010	2023-01-31	4
GARG VIPIN K PRESIDENT AND CEO	Officer Director	238,601	2023-01-31	13
ROBERTS M SCOT CHIEF SCIENTIFIC OFFICER	Officer	24,944	2023-01-31	6
HARRIS MATTHEW SCOTT CHIEF MEDICAL OFFICER	Officer	17,900	2023-01-31	4
JORDT RAYMOND M CHIEF BUSINESS OFFICER	Officer	0	2023-01-03	2
PISANO WAYNE	Director	8,498	2022-12-22	2
DRUTZ DAVID	Director	20,484	2022-11-18	4
SAYARE MITCHEL	Director	23,500	2022-09-29	1
GILL JOHN	Director	23,500	2022-09-29	1
JORKASKY DIANE	Director	23,500	2022-09-29	2
HODGES PHILIP	Director	23,500	2022-09-29	1
SCHAFER KLAUS	Director	23,500	2022-09-29	2
BROWN WILLIAM MICHAEL CHIEF FINANCIAL OFFICER	Officer	17,721	2021-07-31	0
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. VHCP CO-INVESTMENT HOLDINGS III, LLC VHCP MANAGEMENT III, LLC VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. VHCP CO-INVESTMENT HOLDINGS II, LLC VHCP MANAGEMENT II, LLC KOH BONG Y SHAH NIMISH P	10% Owner	No longer subject to file	2021-02-25	0
VELOCITY PHARMACEUTICAL HOLDINGS LLC	10% Owner	No longer subject to file	2020-05-14	0
VELOCITY PHARMACEUTICAL HOLDINGS LLC COLLIER DAVID J WATSON JAMES F VELOCITY PHARMA MANAGEMENT, LLC	10% Owner	1,887,250	2019-07-12	0
TASKER SYBIL CHIEF MEDICAL OFFICER	Officer	0	2019-06-17	0
NOVARTIS BIOVENTURES LTD NOVARTIS AG	10% Owner	No longer subject to file	2018-10-02	0
ENRIGHT WILLIAM PRESIDENT AND CEO	Officer Director	365,839	2018-05-25	0
TRUFFLE CAPITAL S.A.S.	10% Owner	2,161,802	2018-02-13	0
SCHAFFER DERACE L	Director	1,152,600	2017-12-28	0
HODGES PHILIP REDMONT VAXN CAPITAL HOLDINGS, LLC	Director	0	2017-10-13	1
CZEREPAK ELIZABETH CFO AND EVP CORP. DEVELOPMENT	Officer	0	2017-09-22	0
HODGES PHILIP REDMONT VAXN CAPITAL HOLDINGS, LLC PARADIGM VENTURE PARTNERS, L.P. REDMONT VENTURE PARTNERS, INC.	Director 10% Owner	0	2017-05-04	0
RUNGE JEFFREY W.	Director	197,700	2017-01-20	0
ST PETER STEVEN	Director	205,004	2017-01-04	0
MACNEILL PHILIP VP, CFO, TREASURER, SECRETARY	Officer	126,346	2016-12-21	0
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. FROHLICH PHIL	10% Owner	No longer subject to file	2016-12-07	0
RICHMAN ERIC I	Director	908,055	2016-11-22	0
JONES JEFFREY MICHAEL COO	Officer	27,544	2015-03-11	0
CHANG LINDA L SVP, CFO & SECRETARY	Officer	30,000	2015-01-07	0
MARKISON BRIAN A	Director	0	2014-12-31	0
MCCLEARY JOEL	Director	0	2014-12-31	0
COOK FRANCESCA M SVP, POLICY & GOV'T AFFAIRS	Officer	0	2014-12-08	0
MORGES WAYNE SVP, REG. AFFAIRS & QUALITY	Officer	0	2014-12-08	0
KARP JORDAN P SVP, GENERAL COUNSEL	Officer	0	2012-12-03	0
FUERST THOMAS RICHARD EVP, CHIEF SCIENTIFIC OFFICER	Officer	0	2011-12-01	0
PAPPAJOHN JOHN	Director	0	2011-06-23	0
RIDDLE VALERIE D SVP, MEDICAL DIRECTOR	Officer	44,436	2011-05-25	0
REINHART CHARLES A. III SVP, CHIEF FINANCIAL OFFICER	Officer	0	2010-12-08	0
HEALTHCARE VENTURES VII LP LAWLOR AUGUSTINE LITTLECHILD JOHN W MIRABELLI CHRISTOPHER WERNER HAROLD R CAVANAUGH JAMES H HEALTHCARE PARTNERS VII, L.P.	Director 10% Owner	4,253,057	2010-11-03	0
EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT SIMON NICHOLAS J III	10% Owner	6,347,614	2010-11-03	0
MPM BIOVENTURES III LLC MPM BIOVENTURES III PARALLEL FUND, L.P. MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG MPM BIOVENTURES III L.P. MPM BIOVENTURES III GP L.P. MPM BIOVENTURES III-QP L.P. MPM ASSET MANAGEMENT INVESTORS 2004 BVIII LLC	10% Owner	6,347,614	2010-11-03	0
CAVANAUGH JAMES H	Director 10% Owner	0	2010-06-23	0
FUSCO JOAN SVP, OPERATIONS	Officer	0	2010-05-06	0
CAMUT CHRISTOPHER C VP, GOV'T CONTRACTS	Officer	No longer subject to file	2010-01-21	0
WRIGHT DAVID P PRESIDENT AND CEO	Officer Director	399,500	2009-12-11	0
PRICE KEVIN PRESIDENT - PHARMATHENE UK,LTD	Officer	0	2009-01-21	0
HEALTHCARE VENTURES VII LP HEALTHCARE PARTNERS VII, L.P. CAVANAUGH JAMES H LITTLECHILD JOHN W WERNER HAROLD R LAWLOR AUGUSTINE MIRABELLI CHRISTOPHER AGUIAR ERIC	Director 10% Owner	5,109,690	2007-08-03	0
MILLENCO, L.L.C. MILLENNIUM MANAGEMENT, L.L.C. ENGLANDER ISRAEL A	10% Owner	1,200,000	2007-08-03	0
GADICKE ANSBERT	10% Owner	996	2007-08-03	0
BERGER EDWARD B	FORMER DIRECTOR	22,500	2007-08-03	0
SCHELLHAMMER WAYNE A	FORMER DIRECTOR	22,500	2007-08-03	0
KINLEY MATTHEW P	FORMER PRESIDENT & TREASURER	611,980	2007-08-03	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER	2023-02-02 17:11:14 -0500	2023-02-01	M	6,166		d	12,332	direct
ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER	2023-02-02 17:11:14 -0500	2023-02-01	F	2,183	$13.78	d	14,456	direct
ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER	2023-02-02 17:11:14 -0500	2023-02-01	M	6,166		a	16,639	direct
HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER	2023-02-02 17:10:41 -0500	2023-02-01	M	6,166		d	12,332	direct
HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER	2023-02-02 17:10:41 -0500	2023-02-01	F	2,183	$13.78	d	17,900	direct
HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER	2023-02-02 17:10:41 -0500	2023-02-01	M	6,166		a	20,083	direct
GARG VIPIN K - Director - Officer PRESIDENT AND CEO	2023-02-02 17:09:43 -0500	2023-02-01	M	16,546		d	33,090	direct
GARG VIPIN K - Director - Officer PRESIDENT AND CEO	2023-02-02 17:09:43 -0500	2023-02-01	F	7,658	$13.78	d	238,601	direct
GARG VIPIN K - Director - Officer PRESIDENT AND CEO	2023-02-02 17:09:43 -0500	2023-02-01	M	16,546		a	246,259	direct
ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER	2023-02-02 17:11:14 -0500	2023-01-31	A	1,436	$10.21	a	10,473	direct
HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER	2023-02-02 17:10:41 -0500	2023-01-31	A	1,296	$10.21	a	13,917	direct
GARG VIPIN K - Director - Officer PRESIDENT AND CEO	2023-02-02 17:09:43 -0500	2023-01-31	A	1,938	$10.21	a	229,713	direct
EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER	2023-02-02 17:09:00 -0500	2023-01-31	A	1,172	$10.21	a	12,010	direct
GARG VIPIN K - Director - Officer PRESIDENT AND CEO	2023-02-01 17:33:13 -0500	2023-01-30	A	302,900		a	302,900	direct
GARG VIPIN K - Director - Officer PRESIDENT AND CEO	2023-02-01 17:33:13 -0500	2023-01-30	A	107,100		a	107,100	direct
ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER	2023-02-01 17:31:51 -0500	2023-01-30	A	37,100		a	37,100	direct
ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER	2023-02-01 17:31:51 -0500	2023-01-30	A	105,000		a	105,000	direct
EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER	2023-02-01 17:31:05 -0500	2023-01-30	A	37,100		a	37,100	direct
EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER	2023-02-01 17:31:05 -0500	2023-01-30	A	105,000		a	105,000	direct
HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER	2023-02-01 17:30:31 -0500	2023-01-30	A	37,100		a	37,100	direct
HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER	2023-02-01 17:30:31 -0500	2023-01-30	A	105,000		a	105,000	direct
JORDT RAYMOND M - Officer CHIEF BUSINESS OFFICER	2023-01-04 16:06:00 -0500	2023-01-03	A	37,500		a	37,500	direct
JORDT RAYMOND M - Officer CHIEF BUSINESS OFFICER	2023-01-04 16:06:00 -0500	2023-01-03	A	125,000		a	125,000	direct
EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER	2023-01-03 17:59:54 -0500	2022-12-31	M	12,500		d	37,500	direct
EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER	2023-01-03 17:59:54 -0500	2022-12-31	F	3,028	$16.45	d	10,838	direct		-3.1735	5.1317		5.1317	6	-5.6718	4
EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER	2023-01-03 17:59:54 -0500	2022-12-31	M	12,500		a	13,866	direct		-3.1735	5.1317		5.1317	6	-5.6718	4
PISANO WAYNE - Director	2022-12-22 16:05:36 -0500	2022-12-22	M	20,000	$2.60	a	28,498	direct		-3.3268	1.9569		7.3059	5	-3.8487	3
PISANO WAYNE - Director	2022-12-22 16:05:36 -0500	2022-12-22	M	20,000		d	0	direct
PISANO WAYNE - Director	2022-12-22 16:05:36 -0500	2022-12-22	S	20,000	$15.01	d	8,498	direct	yes	-3.3268	1.9569		7.3059	5	-3.8487	3

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available
ALTIMMUNE INC ALT	2023-02-03 22:15:03 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 21:45:03 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 21:15:03 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 20:45:06 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 20:15:04 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 19:45:03 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 19:15:04 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 18:45:03 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 18:15:03 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 17:45:03 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 17:15:04 UTC	4.0397	0.5303	2000000
ALTIMMUNE INC ALT	2023-02-03 16:45:04 UTC	4.042	0.528	2000000
ALTIMMUNE INC ALT	2023-02-03 16:15:03 UTC	4.042	0.528	2000000
ALTIMMUNE INC ALT	2023-02-03 15:45:03 UTC	4.042	0.528	2000000
ALTIMMUNE INC ALT	2023-02-03 15:15:03 UTC	4.042	0.528	2000000
ALTIMMUNE INC ALT	2023-02-03 14:45:04 UTC	3.8375	0.4825	2000000
ALTIMMUNE INC ALT	2023-02-03 14:15:04 UTC	3.8375	0.4825	2000000
ALTIMMUNE INC ALT	2023-02-03 13:45:03 UTC	3.8375	0.4825	2000000
ALTIMMUNE INC ALT	2023-02-03 13:15:03 UTC	3.8375	0.4825	1900000
ALTIMMUNE INC ALT	2023-02-03 12:45:03 UTC	3.8375	0.4825	1900000

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin

No recent transactions

* To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page*

Stock Split History:

09/14/2018: 1:30

Elevate your investments